SOADOR
KNSA icon

State of Alaska Department of Revenue’s Kiniksa Pharmaceuticals KNSA Stock Holding History

State of Alaska Department of Revenue’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Hold
2,268
– – ﹤0.01% 1699
2026
Q1 		$109K Hold
2,268
– – ﹤0.01% 1749
2025
Q4 		$93K Hold
2,268
– – ﹤0.01% 1790
2025
Q3 		$88K Buy
+2,268
New +$73.7K ﹤0.01% 1694

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

State of Alaska Department of Revenue's KNSA Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 2,268 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

State of Alaska Department of Revenue first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 170 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • State of Alaska Department of Revenue held 2,268 shares of Kiniksa Pharmaceuticals worth $145K as of Q2 2026.
  • State of Alaska Department of Revenue left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1699 holding.
  • State of Alaska Department of Revenue first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 170 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.